Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

by Josep Carreras Leukaemia Research InstituteComparative in vitro study of engineered CD1a-STAb and CD1a-CAR T cells. (A, B) Schematic diagrams showing the genetic (A) and domain structure (B) o

Updated on: February 18,2024

Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

by Josep Carreras Leukaemia Research InstituteComparative in vitro study of engineered CD1a-STAb and CD1a-CAR T cells. (A, B) Schematic diagrams showing the genetic (A) and domain structure (B) o

Updated on:February 18,2024

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on: January 21,2024

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on:January 21,2024

Finances need to be a bigger part of our conversation about cancer, researchers say

by Maddie Massy-Westropp,University of New South WalesCredit: Unsplash/CC0 Public DomainWhen Jessie Oldfield was experiencing some bleeding at 23 weeks pregnant, she was worried that she had pre

Updated on: February 18,2024

Finances need to be a bigger part of our conversation about cancer, researchers say

by Maddie Massy-Westropp,University of New South WalesCredit: Unsplash/CC0 Public DomainWhen Jessie Oldfield was experiencing some bleeding at 23 weeks pregnant, she was worried that she had pre

Updated on:February 18,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on: January 22,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on:January 22,2024

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on: April 01,2024

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on:April 01,2024

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Updated on: March 30,2024

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Updated on:March 30,2024

Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t

Updated on: February 18,2024

Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t

Updated on:February 18,2024

Researchers artificially generate immune cells integral to creating cancer vaccines

by The Mount Sinai HospitalArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Credit: National Institutes of H

Updated on: June 06,2024

Researchers artificially generate immune cells integral to creating cancer vaccines

by The Mount Sinai HospitalArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Credit: National Institutes of H

Updated on:June 06,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on: March 30,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on:March 30,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on: March 30,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on:March 30,2024

Nutritional cues regulate pancreatic tumor's 'cell drinking'

by Sanford Burnham Prebys Medical Discovery InstituteCosimo Commisso, Ph.D., assistant professor in Sanford Burnham Prebys' NCI-designated Cancer Center. Credit: Sanford Burnham PrebysDespera

Updated on: May 11,2024

Nutritional cues regulate pancreatic tumor's 'cell drinking'

by Sanford Burnham Prebys Medical Discovery InstituteCosimo Commisso, Ph.D., assistant professor in Sanford Burnham Prebys' NCI-designated Cancer Center. Credit: Sanford Burnham PrebysDespera

Updated on:May 11,2024